» Authors » Robbie Foy

Robbie Foy

Explore the profile of Robbie Foy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 137
Citations 3624
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Seymour V, Willis T, Weller A, Althaf M, Francis J, Lorencatto F, et al.
Health Informatics J . 2025 Mar; 31(1):14604582251317101. PMID: 40081406
Audit and feedback (A&F) programmes aim to improve patient care by providing summary data on performance to clinicians. They generally have modest, but variable, effects on patient care and questions...
2.
Turner G, Calvert M, Foy R, Atkins L, Collis P, Tearne S, et al.
PLoS One . 2025 Mar; 20(3):e0317425. PMID: 40080521
Background: Care following transient ischaemic attack (TIA) and minor stroke is variable and often leaves patients feeling abandoned and uncertain. We developed a theoretically-informed, multifaceted intervention which comprised nurse-led, structured...
3.
Shah A, Evans H, Palmer A, MacDonald A, Belete M, von Neree L, et al.
BJA Open . 2025 Feb; 13:100372. PMID: 39968291
Background: Perioperative red blood cell (RBC) transfusion is a common intervention in patients undergoing surgery but there is marked variation in practice. Key performance indicators (KPIs) are central to identifying...
4.
Strickland L, Evans H, Palmer A, Warnakulasuriya S, Murphy M, Stanworth S, et al.
Br J Haematol . 2025 Feb; 206(3):965-976. PMID: 39966105
Despite robust supporting evidence, around a third of eligible surgical patients do not receive tranexamic acid (TXA). Effective strategies based on an understanding of clinical behaviour are needed to increase...
5.
Smith S, Green S, McNaught E, Graham C, Foy R, Loo Ow P, et al.
Ann Behav Med . 2025 Jan; 59(1). PMID: 39887069
Background: Adherence to adjuvant endocrine therapy (AET) in women with breast cancer is poor. Multicomponent intervention packages are needed to address adherence barriers. Optimizing these packages prior to definitive evaluation...
6.
Wright-Hughes A, Ow P, Alderson S, Ridd M, Foy R, Bishop F, et al.
Gut . 2025 Jan; PMID: 39863398
Background: Low-dose amitriptyline, a tricyclic antidepressant (TCA), was superior to placebo for irritable bowel syndrome (IBS) in the AmitripTyline at Low-dose ANd Titrated for Irritable bowel syndrome as Second-line treatment...
7.
Heaven A, Foster M, Foy R, Hawkins R, Hulme C, Humphrey S, et al.
BJGP Open . 2025 Jan; PMID: 39753326
Background: Frailty increases vulnerability to major health changes because of seemingly small health problems. It affects around 10% of people aged over 65.Older adults with frailty frequently have multiple long-term...
8.
Green S, Graham C, Collinson M, Loo Ow P, Hall L, French D, et al.
Transl Behav Med . 2024 Dec; 15(1. PMID: 39657026
Adherence to adjuvant endocrine therapy in women with breast cancer is low. We conducted a 24-1 fractional factorial pilot optimization trial to test four intervention components supporting medication adherence [text...
9.
Bellass S, Canvin K, Farragher T, McLintock K, Wright N, Hearty P, et al.
Health Soc Care Deliv Res . 2024 Nov; 12(46):1-329. PMID: 39514203
Background: People in prison are generally in poorer health than their peers in the community, often living with chronic illness and multimorbidity. Healthcare research in prisons has largely focused on...
10.
Wright-Hughes A, Ford A, Alderson S, Loo Ow P, Ridd M, Foy R, et al.
Health Technol Assess . 2024 Oct; 28(66):1-161. PMID: 39397570
Background: Irritable bowel syndrome, characterised by abdominal pain and a change in stool form or frequency, is most often managed in primary care. When first-line therapies are ineffective, National Institute...